SE313809B - - Google Patents

Info

Publication number
SE313809B
SE313809B SE11026/62A SE1102662A SE313809B SE 313809 B SE313809 B SE 313809B SE 11026/62 A SE11026/62 A SE 11026/62A SE 1102662 A SE1102662 A SE 1102662A SE 313809 B SE313809 B SE 313809B
Authority
SE
Sweden
Application number
SE11026/62A
Inventor
H Smith
G Hughes
Original Assignee
H Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Smith filed Critical H Smith
Publication of SE313809B publication Critical patent/SE313809B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A43FOOTWEAR
    • A43BCHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B3/00Footwear characterised by the shape or the use
    • A43B3/12Sandals; Strap guides thereon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Woven Fabrics (AREA)
  • Manufacturing Of Printed Wiring (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
SE11026/62A 1961-10-19 1962-10-15 SE313809B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB37618/61A GB1041279A (en) 1961-10-19 1961-10-19 13-alkyl steroid ketones

Publications (1)

Publication Number Publication Date
SE313809B true SE313809B (en:Method) 1969-08-25

Family

ID=10397775

Family Applications (6)

Application Number Title Priority Date Filing Date
SE01423/67A SE335526B (en:Method) 1961-10-19 1962-10-15
SE11024/62A SE312552B (en:Method) 1961-10-19 1962-10-15
SE11026/62A SE313809B (en:Method) 1961-10-19 1962-10-15
SE11023/62A SE312551B (en:Method) 1961-10-19 1962-10-15
SE11025/62A SE312553B (en:Method) 1961-10-19 1962-10-15
SE05984/66A SE340619B (en:Method) 1961-10-19 1966-05-02

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE01423/67A SE335526B (en:Method) 1961-10-19 1962-10-15
SE11024/62A SE312552B (en:Method) 1961-10-19 1962-10-15

Family Applications After (3)

Application Number Title Priority Date Filing Date
SE11023/62A SE312551B (en:Method) 1961-10-19 1962-10-15
SE11025/62A SE312553B (en:Method) 1961-10-19 1962-10-15
SE05984/66A SE340619B (en:Method) 1961-10-19 1966-05-02

Country Status (12)

Country Link
AT (4) AT264730B (en:Method)
CH (5) CH450407A (en:Method)
CY (1) CY429A (en:Method)
DE (4) DE1617818B2 (en:Method)
DK (6) DK113641B (en:Method)
ES (1) ES281669A1 (en:Method)
FI (4) FI41025B (en:Method)
FR (1) FR2796M (en:Method)
GB (2) GB1041279A (en:Method)
MY (1) MY6800075A (en:Method)
NO (4) NO122645B (en:Method)
SE (6) SE335526B (en:Method)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2636404C2 (de) * 1976-08-12 1983-12-08 Schering AG, 1000 Berlin und 4709 Bergkamen Δ↑1↑↑5↑-17α-Äthinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
CN104926906B (zh) * 2015-06-04 2016-02-10 保定北瑞甾体生物有限公司 一种17α-羟基黄体酮的制备方法

Also Published As

Publication number Publication date
CH450408A (de) 1968-01-31
DE1468604C2 (de) 1971-03-04
DK129652B (da) 1974-11-04
CH450407A (de) 1968-01-31
DK129652C (en:Method) 1975-04-07
DE1793595A1 (de) 1972-02-03
FI41025B (en:Method) 1969-04-30
DK115621B (da) 1969-10-27
FI41024B (en:Method) 1969-04-30
AT256354B (de) 1967-08-25
DE1618855B2 (de) 1973-04-05
CH459195A (de) 1968-07-15
FI41026B (en:Method) 1969-04-30
SE340619B (en:Method) 1971-11-29
SE312552B (en:Method) 1969-07-21
MY6800075A (en) 1968-12-31
DE1468604B1 (de) 1970-07-02
SE335526B (en:Method) 1971-06-01
DE1617818B2 (de) 1976-12-09
CH455763A (de) 1968-05-15
DK115549B (da) 1969-10-20
NO122645B (en:Method) 1971-07-26
CY429A (en) 1968-01-15
DK124753B (da) 1972-11-20
SE312551B (en:Method) 1969-07-21
DE1793608B1 (de) 1972-05-04
DE1618855C3 (en:Method) 1973-10-25
GB1041279A (en) 1966-09-01
AT256356B (de) 1967-08-25
NO122644B (en:Method) 1971-07-26
FR2796M (fr) 1964-09-21
NO122646B (en:Method) 1971-07-26
AT264730B (de) 1968-09-10
NO122643B (en:Method) 1971-07-26
CH432509A (de) 1967-03-31
ES281669A1 (es) 1963-03-16
GB1041278A (en) 1966-09-01
FI41027B (en:Method) 1969-04-30
DK113641B (da) 1969-04-14
DK121228B (da) 1971-09-27
DE1618855A1 (de) 1972-05-18
SE312553B (en:Method) 1969-07-21
DE1617818A1 (de) 1972-05-18
AT256355B (de) 1967-08-25
DE1793595B2 (de) 1975-10-30

Similar Documents

Publication Publication Date Title
DK129652C (en:Method)
BE601744A (en:Method)
BE601847A (en:Method)
BE621674A (en:Method)
BE617340A (en:Method)
BE615684A (en:Method)
BE615000A (en:Method)
BE613181A (en:Method)
BE611667A (en:Method)
BE605802A (en:Method)
BE602558A (en:Method)
BE602469A (en:Method)
BE602240A (en:Method)
BE602153A (en:Method)
BE601041A (en:Method)
BE601970A (en:Method)
BE638910A (en:Method)
BE601846A (en:Method)
BE601844A (en:Method)
BE458606A (en:Method)
BE622201A (en:Method)
BE601679A (en:Method)
BE623050A (en:Method)
BE621906A (en:Method)
BE624825A (en:Method)